J147
J147[edit]
J147 is a synthetic compound that has been investigated for its potential therapeutic effects in neurodegenerative diseases, particularly Alzheimer's disease. It was developed by researchers at the Salk Institute for Biological Studies and has shown promise in preclinical studies for its ability to improve cognitive function and protect against neurodegeneration.
Chemical Properties[edit]
J147 is a derivative of the natural product curcumin, which is found in the spice turmeric. The chemical structure of J147 is designed to enhance its bioavailability and blood-brain barrier penetration compared to curcumin. The compound is characterized by its ability to modulate multiple biological pathways associated with aging and neurodegeneration.
Mechanism of Action[edit]
J147 has been shown to interact with several molecular targets, including the mitochondrial ATP synthase, which plays a crucial role in cellular energy production. By modulating this enzyme, J147 is thought to enhance mitochondrial function and reduce the production of reactive oxygen species, thereby protecting neurons from oxidative stress.
Additionally, J147 has been reported to increase levels of brain-derived neurotrophic factor (BDNF), a protein that supports the survival and growth of neurons. This action may contribute to its neuroprotective and cognitive-enhancing effects.
Potential Therapeutic Applications[edit]
J147 is primarily being studied for its potential use in treating Alzheimer's disease. In animal models, it has been shown to improve memory and cognitive function, reduce amyloid-beta levels, and decrease inflammation in the brain. These findings suggest that J147 could be a promising candidate for further development as a treatment for Alzheimer's disease.
Beyond Alzheimer's, J147 may have applications in other age-related cognitive disorders and neurodegenerative diseases, although more research is needed to fully understand its therapeutic potential and safety profile.
Research and Development[edit]
Research on J147 is ongoing, with studies focusing on its efficacy, safety, and mechanism of action. Clinical trials will be necessary to determine its potential as a therapeutic agent in humans. The development of J147 is part of a broader effort to find new treatments for neurodegenerative diseases by targeting the underlying mechanisms of aging.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
